Development of a novel rabeprazole modified release formulation to reduce the dosing frequency: A trial and triumph with physiologically based biopharmaceutics modeling
- DOI
- 10.1007/s10928-026-10035-w
- Published
- 2026-05-16
- Container
- Journal of Pharmacokinetics and Pharmacodynamics
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10928-026-10035-w,
title = {Development of a novel rabeprazole modified release formulation to reduce the dosing frequency: A trial and triumph with physiologically based biopharmaceutics modeling},
author = {Harika Maddukuri and Rajkumar Boddu and Sangmesh Mallikarjun Chaudhari and Anup Avijit Choudhury and Veena Kambam and Sohel Mohammed Khan and Venkat Ramana Naidu and Sanjay Kumar Singh and Anuj Kumar Saini and Sivacharan Kollipara},
year = {2026},
journal = {Journal of Pharmacokinetics and Pharmacodynamics},
doi = {10.1007/s10928-026-10035-w},
url = {https://doi.org/10.1007/s10928-026-10035-w}
}RIS
TY - JOUR TI - Development of a novel rabeprazole modified release formulation to reduce the dosing frequency: A trial and triumph with physiologically based biopharmaceutics modeling AU - Harika Maddukuri AU - Rajkumar Boddu AU - Sangmesh Mallikarjun Chaudhari AU - Anup Avijit Choudhury AU - Veena Kambam AU - Sohel Mohammed Khan AU - Venkat Ramana Naidu AU - Sanjay Kumar Singh AU - Anuj Kumar Saini AU - Sivacharan Kollipara PY - 2026 JO - Journal of Pharmacokinetics and Pharmacodynamics DO - 10.1007/s10928-026-10035-w UR - https://doi.org/10.1007/s10928-026-10035-w ER -
APA
Maddukuri, H., Boddu, R., Chaudhari, S. M., Choudhury, A. A., Kambam, V., Khan, S. M., Naidu, V. R., Singh, S. K., Saini, A. K., & Kollipara, S. (2026). Development of a novel rabeprazole modified release formulation to reduce the dosing frequency: A trial and triumph with physiologically based biopharmaceutics modeling. Journal of Pharmacokinetics and Pharmacodynamics. https://doi.org/10.1007/s10928-026-10035-w
Source records
- crossref · retrieved 2026-09-27T10:14:19.882Z